Previous 10 | Next 10 |
2024-01-14 14:04:11 ET Summary AngioDynamics' latest quarter earnings missed expectations. The company is facing weaker-than-anticipated sales following the rollout of new products forcing management to revise lower full-year guidance. We expect shares to remain volatile until...
2024-01-06 02:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-01-05 15:35:01 ET Investors in AngioDynamics (NASDAQ: ANGO) , inventor of the innovative Nanoknife device for electrocuting cancer cells , got an unpleasant shock of their own on Friday morning. Though the company reported a smaller adjusted loss than had been forecast for ...
2024-01-05 12:31:54 ET Gainers: Revelstone Capital Acquisition Corp ( RCAC ) +90% . Ainos ( AIMD ) +72% . Banzai International ( BNZI ) +62% . Safe and Green Development ( SGD ) +41% . Swvl Holdings ( SWVL ) +41% . Zoomcar Ho...
2024-01-05 10:26:03 ET AngioDynamics, Inc. (ANGO) Q2 2024 Earnings Conference Call January 05, 2024, 08:00 AM ET Company Participants Jim Clemmer - President and CEO Steve Trowbridge - EVP and CFO Conference Call Participants Yi Chen - H.C. Wainwright ...
2024-01-05 10:00:03 ET More on Health Care Select Sector SPDR XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Covid-vaccine makers top laggard list, LLY and WST top gainers list Healthcare and uti...
2024-01-05 07:09:08 ET More on AngioDynamics Execution Issues Continue To Undermine The AngioDynamics Story Seeking Alpha’s Quant Rating on AngioDynamics Historical earnings data for AngioDynamics Financial information for AngioDynamics For fur...
Fiscal Year 2024 Second Quarter Highlights Net sales of $79.1 million increased 2.7% on a pro-forma basis compared to the prior-year quarter Med Tech net sales of $25.4 million increased 3.5% Med Device net sales of $53.7 million increased 2.3% on a pro-forma basis ...
Spark New Zealand Limited ADR (SPKKY) is expected to report for Q1 2024 Taylor Devices Inc. (TAYD) is expected to report for Q1 2024 American Biltrite Inc. (ABLT) is expected to report for quarter end 2023-09-30 Cognetivity Neurosciences Ltd (CGNSF) is expected to report for Q3 2024 ...
2024-01-04 10:55:52 ET More on AngioDynamics Execution Issues Continue To Undermine The AngioDynamics Story Seeking Alpha’s Quant Rating on AngioDynamics Historical earnings data for AngioDynamics Financial information for AngioDynamics For fur...
News, Short Squeeze, Breakout and More Instantly...
Equity Bancshares Inc. Class A (EQBK) is expected to report $0.92 for Q2 2024 Bank of America Corporation (BAC) is expected to report $0.79 for Q2 2024 Aehr Test Systems (AEHR) is expected to report $0.09 for Q4 2024 America Movil S.A.B. de C.V.n Depositary Shares (each representing t...
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients, today announced financial results for the fourt...
AZZ Inc. (AZZ) is expected to report $1.31 for Q1 2025 Express Inc. (EXPRQ) is expected to report for Q1 2025 Aeon Co. Ltd. ADR (AONNY) is expected to report for Q1 2025 Altamira Therapeutics Ltd. (CYTO) is expected to report for Q1 2024 Bassett Furniture Industries Incorporated (...